Education
About Us
Working with TipRanks
Follow Us
ExpreS2ion Biotech Holding AB (SE:EXPRS2)
:EXPRS2
EXPRS2 Stock Chart & Stats
kr15.82
-kr1.20(-4.51%)
At close: 4:00 PM EST
kr15.82
-kr1.20(-4.51%)
Day’s Range― - ―
52-Week Rangekr14.64 - kr34.20
Previous CloseN/A
Volume135.00
Average Volume (3M)19.88K
Market Cap
€58.25M
Enterprise Valuekr16.41M
Total Cash (Recent Filing)€36.88M
Total Debt (Recent Filing)€1.51M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Feb 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.18
Shares Outstanding3,530,233
10 Day Avg. Volume26,629
30 Day Avg. Volume19,883
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.54
Price to Sales (P/S)11.56
P/FCF Ratio-1.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EXPRS2 FAQ
What was ExpreS2ion Biotech Holding AB’s price range in the past 12 months?
ExpreS2ion Biotech Holding AB lowest stock price was kr14.64 and its highest was kr34.20 in the past 12 months.
What is ExpreS2ion Biotech Holding AB’s market cap?
ExpreS2ion Biotech Holding AB’s market cap is €58.25M.
When is ExpreS2ion Biotech Holding AB’s upcoming earnings report date?
ExpreS2ion Biotech Holding AB’s upcoming earnings report date is Feb 19, 2026 which is in 66 days.
How were ExpreS2ion Biotech Holding AB’s earnings last quarter?
ExpreS2ion Biotech Holding AB released its earnings results on Nov 13, 2025. The company reported -kr3.177 earnings per share for the quarter, missing the consensus estimate of N/A by -kr3.177.
Is ExpreS2ion Biotech Holding AB overvalued?
According to Wall Street analysts ExpreS2ion Biotech Holding AB’s price is currently Overvalued.
Does ExpreS2ion Biotech Holding AB pay dividends?
ExpreS2ion Biotech Holding AB does not currently pay dividends.
What is ExpreS2ion Biotech Holding AB’s EPS estimate?
ExpreS2ion Biotech Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ExpreS2ion Biotech Holding AB have?
ExpreS2ion Biotech Holding AB has 3,530,233 shares outstanding.
What happened to ExpreS2ion Biotech Holding AB’s price movement after its last earnings report?
ExpreS2ion Biotech Holding AB reported an EPS of -kr3.177 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.293%.
Which hedge fund is a major shareholder of ExpreS2ion Biotech Holding AB?
Currently, no hedge funds are holding shares in SE:EXPRS2
Company Description
ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB (EXPRS2) is a biotechnology company specializing in the development of innovative solutions for antibody production and other biopharmaceutical applications. The company operates primarily in the life sciences sector, focusing on its proprietary ExpreS2 platform, which enables rapid and cost-effective production of high-quality proteins and antibodies. ExpreS2ion aims to support pharmaceutical companies and research institutions in their efforts to develop novel therapies, particularly in the areas of cancer and infectious diseases.
Technical Analysis
OncoZenge AB
―
Stayble Therapeutics AB
―
CombiGene AB
―
Sprint Bioscience AB
―
AcouSort AB
―